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1 Introduction: Challenges in health care 
Populations of developed economies are ageing and those of developing economies 
are growing due to a significant demographic change (United Nations, 2002; 2009). 
Western countries such as Germany, the U.S., and France witness diminishing birth 
rates and an increasing life expectancy. As a consequence, these countries are exposed 
to growing health care costs at an unsustainable rate, one which is roughly twice 
the rate of economic growth (OECD, 2010). This development calls for rebalancing 
efficiency and health care costs while improving quality of care for patients.
While other big industries than health care have adopted the advantages of the 
information technology (IT) age since the 1980s (Schepers, Schnell, & Vroom, 1999; 
Von Hippel, 1988), the health care sector has been quite hesitating to do similarly. 
Now, the influence of technological advance on health care is likely to further increase 
(Randeree, 2009). One of the recent developments, which is termed health 2.0, has 
been the use of Internet or web-based technology in health care (Oh, Rizo, Enkin, & 
Jadad, 2005; Van De Belt, Engelen, Berben, & Schoonhoven, 2010). Recent studies 
give evidence that the number of Internet users worldwide, who go online for health-
related purposes, is growing significantly (Kummervold et al., 2008). Over the past 
few years, many virtual communities for patients have arisen to give information 
about disorders and facilitate networking with like-minded sufferers. The web sites 
help patients to better understand and manage one’s individual health status. Some 
reports herald that it is a powerful and disruptive means to changing current patients’ 
role and medical practice. Some research has been done to better understand how 
to systematically develop and operate virtual communities in health care (e.g., 
Leimeister & Krcmar, 2006). 
The aim of the study at hand is to gain insight into the current developments in the 
domain of health 2.0 and to examine IT-based communities on the Internet that foster 
the emergence of patient interaction. At first, we present the background of web 2.0 
in health care (cf. chapter 2). Subsequently, we present four exemplary case studies 
(cf. chapter 3), followed by a discussion on possible dimensions of how to classify 
health 2.0 platforms (cf. chapter 4). Concluding remarks on limitations and future 
research closes the paper.
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2 Setting the scene: Web 2.0 in health care
The term web 2.0 was initially introduced following the O’Reilly Media Web 2.0 
conference in 2004. It summarizes the changes that had happened on the Internet 
and the way how its users deal with it. A set of economic, social, and technological 
trends led to the next generation Internet which is characterized by user participation, 
openness, and network effects (Musser & O´Reilly, 2007; O´Reilly, 2005). Compared 
to Web 1.0, the so-called first generation of the Internet, the difference of Web 2.0 
is foremost about user interaction. While Web 1.0 was mainly about unidirectional 
information retrieval, users can create and add information and content to the Web. 
For that reason the amount of user-generated content has increased enormously 
(OECD, 2007). Since then online communities, in which users can participate and 
share content, have become very popular.
This recent trend has also shown impact on health care related online offers which 
is then described as health 2.0 or medicine 2.0 (Eysenbach, 2008; Hughes, Joshi, 
& Wareham, 2008; Van De Belt, Engelen, Berben, & Schoonhoven, 2010). Both 
terms cannot be separated distinctly, and are sometimes used synonymously. They 
are subsumed in the broader term e-health which was first introduced in 2000 in the 
context of telemedicine (Mitchell, 2000). Van de Belt et al. (2010) have undertaken 
a literature review in health 2.0 and medicine 2.0. They conclude by finding seven 
leading themes within all definitions:
1) Increased participation or empowerment of patients or consumers of health 
care,
2) Web 2.0 as the underlying technology for communication and information 
sharing,
3) Apart from patients only, increased participation or empowerment of health 
professionals or other stakeholders, e.g. payers, providers, researchers,
4) Emergence of online communities and social networking in health 2.0,
5) Positive impact or change on the health care system in terms of higher quality 
and efficiency in health care,
6) Improving collaboration between patients and health professionals, and
7) Stronger focus on health information and content, one that is patient-driven or 
user-generated.
At this point, health 2.0 platforms seem promising for two reasons. Firstly, the web 
2.0 provides features that help to give users an active voice on the Internet. Compared 
to the first generation of the Internet, web 2.0 is foremost characterized by user 
participation, openness, and network effects (Musser & O´Reilly, 2007). Accordingly, 
health 2.0 platforms can leverage patients’ knowledge base through user interaction. 
It is particularly important to obtain both need information and solution information 
from the patient as both types of information are crucial to value-creation in new 
product and service development (Reichwald & Piller, 2009; Thomke, 2003; Von 
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Hippel, 1994). Traditionally solution information was provided by the manufacturer 
of a product, but now user interaction in health 2.0 can help to transfer this valuable 
knowledge from the patients’ minds to a public space like online communities from 
where it can be harvested by manufacturers.
Secondly, patients obtain easier access to health-related information and thereby 
are able to gain better understanding of their health status. In peer-led patient 
communities, not only provide users each other with knowledge and support, they 
also enable one another to comprehend the necessary medical information and science 
in the context of the respective disorder (Frost & Massagli, 2008; Hoch & Ferguson, 
2005). Such communities are characterized by a high degree of interaction between 
users, and reciprocal exchange of information.
Several studies report that the role of the consumer is transforming into a more 
informed, engaged, and empowered one (Akesson, Saveman, & Nilsson, 2007; 
Bos, Marsh, Carroll, Gupta, & Rees, 2008; Füller, Mühlbacher, Matzler, & Jawecki, 
2009). Also, health 2.0 influences the roles of health professionals and researchers 
and how they interact with empowered patients (Eysenbach, 2008; Wald, Dube, & 
Anthony, 2007). The emergence of these interactive capabilities enable virtual health 
communities to be an effective source of jointly constructed and shared knowledge 
through participation of patients, caregivers, health professionals, and researchers. 
3 Exemplary health 2.0 cases
As practice and research in the field of health 2.0 is still recent, we chose an exploratory 
approach to study contemporary real-world practices on health platforms. In the 
following we present four descriptive case studies, which we consider as promising 
practices. They differ by the different implementation levels of virtual communities. 
3.1 NetDoktor
One of the first health 2.0 platforms in Germany was NetDoktor1 – a portal that 
already went online in 1999. Meanwhile the platform has developed into one of the 
best-known and most visited sites in Germany (Weller, 2009). It addresses a broad 
audience of both the well and the sick.
NetDoktor predominantly serves as a portal providing independent and comprehensive 
information around health and medicine. Online encyclopedia provide hard facts 
and physician editors publish articles on general health advice ranging from alcohol 
abuse over menstruation to vaccinations. Dedicated theme pages are available for 
specific diseases such as asthma, cancer, or swine flu. The business model mainly 
bases on advertising revenue and content licensing, i.e. commercialization of content 
to interested partners. Hence, the quality of the editorial contributions is of key 
importance. 
1 http://www.netdoktor.de
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Moreover, since 2009, NetDoktor has added discussion boards where patients can 
post questions and reply to other’s questions across a variety of health-related topics. 
This function enables users and patients to interact and learn within topic-centered 
communities. As a service feature, the platform offers to its users the search for 
doctors, pharmacy emergency service, and external self-help groups.
3.2 Imedo
Imedo2 is a health 2.0 platform that puts a stronger focus on development of patient 
communities than the previous example. The portal, that was founded in 2007 and 
counts approximately 80,000 registered users, addresses a broad audience across 
various health topics ranging from general health to chronic disorders. Its users are 
health seekers, patients, doctors, or members of self-help groups.
The central function of Imedo is its community. The typical element is discussion boards 
that help users to exchange knowledge and expertise on their health problems. Apart 
from that, Imedo has implemented a number of community features that distinguishes 
it. Outside of the discussion boards, users are able to raise individual questions to 
find quick answers and straight-forward solutions through other experienced users. 
Furthermore, users can formulate individual health goals and a personal buddy in the 
community, called “motivator”, supports and checks on reaching the goal. In each 
personal profile, users have the option to give information about their health-related 
interests, currently used medicines, and applied therapies. This helps to more easily 
find like-minded users and thereby promotes the value of the community network.
In order to combine online and offline world, Imedo operates a search function for 
patients to find medical specialists within Germany. Users can also write reviews 
on a specific doctor, give ratings, and share this information with the community. 
Apart from this, Imedo offers a dictionary of medical terms and a news section that 
complement the discussion boards with hard facts. 
3.3 Gemeinsam für die Seltenen
On the platform GemeinsamSelten3, users can initiate and participate in finding ideas 
and solutions that help sufferers of rare diseases. The site, which has been launched 
in March 2011 and addresses a German-speaking community, accommodates three 
main functional components: an innovation initiative based on a series of contest-like 
challenges, a social network, and a marketplace for exchanging problems and ideas.
The platform strives to collect problems of rare disease patients and, thereby, increase 
public awareness. The aim of the site is to develop innovative solutions for the patients’ 
reported problems through innovation contests. Across the great variety of illnesses, 
patients and their families are often confronted with similar types of problems. The 
2 http://www.imedo.de
3 http://www.gemeinsamselten.de
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site targets people who know about the daily troubles of rare disease patients – may it 
be the patient himself or persons concerned. These people might have thought about 
tricky problems, possible solutions and even practical implementations. However, 
in order to become a participating member, interested people do not have to possess 
experience on rare conditions. The intention of the site is to bring people from diverse 
backgrounds together – if it is caregivers, health workers, physicians, nurses (i.e. core 
inside innovators); family members, friends, fellow patients (i.e. peripheral inside 
innovators); or researchers, engineers, product managers, civil servants (i.e. outside 
innovators). 
The research group behind the platform organizes so-called challenges in which 
participants can compete for the best ideas. During a challenge, which lasts 
approximately three months, participants can present unsolved problems, submit 
solution proposals, and collectively work on refining ideas and concepts. At this point, 
the social community features of the site enable members to create a personal profile, 
connect to others, discuss ideas, and comment on others’ contributions. Proposals for 
solutions on GemeinsamSelten can cover descriptions on technical aids and products, 
medical and caregiving services, medical-technical services, or housekeeping and 
social services.
After the closing date of each challenge, a jury of experts assesses the most innovative 
concepts. The multi-disciplinary jury consists of researchers and practitioners from 
clinical as well as commercial organizations. The jury members evaluate each 
solution proposal along a predefined set of criteria such as novelty, usefulness, 
feasibility, market potential, and degree of elaboration. Not only do final winners 
of the contest collect prizes, but they are also supported in innovation workshops to 
develop concepts for prototypes.
In brief, the platform has three distinctive features; it (i) organizes a series of 
innovation contest-like challenges to find solutions for improving the quality of life 
of rare disease patients, (ii) collects patient’s problems and needs in a central place, 
and (iii) creates a community with people from diverse backgrounds to promote 
knowledge exchange and collaborate on innovative concepts.
3.4 PatientsLikeMe
The platform PatientsLikeMe.com4 is a health information system that looks at first 
glance similar to patient chat rooms and support groups. The site, which has been 
operating since 2006, is specifically designed for patients to meet and discuss with 
other patients about their ailments. With a clear focus on patients facing life-changing 
and rare illnesses, the ~97,000 registered patients (as of March 2011), mainly from the 
U.S. and the U.K., are organized in disease-based communities, such as amyotrophic 
lateral sclerosis (ALS), multiple sclerosis (MS), fibromyalgia, acquired immune 
4 http://www.patientslikeme.com
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deficiency syndrome (AIDS), depression and anxiety. Compared to other platforms 
in the health 2.0 space, PatientsLikeMe has one of the most innovative approaches. 
In this system, patients give detailed record about their health information and, then, 
make it public to the community. The record contains a combination of structured 
and unstructured data about symptoms, severity, progress, medication and their 
side effects. Health data is neatly represented using standardized metrics and clear 
graphical displays. Once shared with other patients, they can enter active dialogue via 
the web platform and learn from collective knowledge and experience.
Another outstanding characteristic of PatientsLikeMe is the dedicated openness 
philosophy within the community – in addition to their privacy policy towards 
non-members. For most online users, protection of private and personal data is an 
imperative that platform operators must adhere to. For patients with incurable and 
life-changing diseases who are looking for ways to prolonging their life, the case 
might be different. The makers of the site assume that open collaboration on a large 
scale with real-world data enables change, and possibly new treatments.
Apart from patients, there is collaboration with several nonprofit groups as well as 
pharmaceutical companies. It is an essential part of the business model. PatientsLikeMe 
is very clear in stating that aggregated anonymous data is sold to drug, device, and 
insurance companies – all with the consent of its members. For example, Novartis and 
Avanir, both research-based pharmaceutical organizations, are partnering with the site 
to recruit participants for clinical studies. These firms can publish online pre-screeners 
on the site that help to select patients who are eligible for e.g. a clinical trial to test 
drugs. In the case of Novartis, it is reported that the site helped to speed an MS trial 
by several months (Arnst, 2008).
In brief, PatientsLikeMe offers (i) graphically enhanced personal health record for 
rare disease patients, (ii) open sharing of personal health data in social network, and 
(iii) matchmaking between patients and researchers.
4 Discussion
In the previous sections we have seen four examples of community interaction 
happening on health 2.0 platforms. Going forward, we discuss potential dimensions 
for classification. In the above discussed examples, the platform user finds himself/
herself linking-up with a variety of stakeholders resulting in a distinct degree of 
interaction between community members. Hence, we assume that the value of the 
patient community largely depends on two major dimensions which are discussed 
in the following.
Firstly, from the perspective of a patient, there are numerous relationships to problem 
solvers who can deal with the patient’s health problems. In the first place, it is the 
relationship to a dedicated general practitioner who typically has the best overview of 
the patient’s health status. In the course of medical treatment, the GP might send the 
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patient to medical specialists for further examination. In addition to the GP, the patient 
could consult other medical experts on a one-to-one basis, ranging from technical 
encyclopedia to health counselors from industry partners. Due to its functional focus 
on serving as an information portal, NetDoktor is a good example which links its users 
up with medical experts in form of physician editors. 
As a consequence of health 2.0, the traditional one-to-one relationship between doctor 
and patient is supplemented by a number of new relationships with like-minded 
people. Here, one major group consists of fellow patients who suffer from a similar 
disease pattern and also their caregivers and family relatives who suffer indirectly. 
They all have acquired relevant experience and knowledge in the same field. Fellow 
sufferers are less familiar with the patient’s detailed situation than the supervising GP 
but still can share relevant experience. Here, the platform Imedo demonstrates how 
users can learn from community members’ experience to solve individual problems.
Other stakeholders who do not directly share disease experience with the patient make 
up a third group. They can contribute specific technical knowledge in order to solve, 
or at least facilitate dealing with, the patient’s health problem. These could be, e.g., 
industry partners like medical device manufacturers or service businesses specialized 
on a particular aspect of medical care. At this point, especially GemeinsamSelten and 
PatientsLikeMe successfully connect patients with medical experts, other patients, 
and further stakeholders.
From the above we propose that the first dimension is about patient-related interaction 
groups consisting of three clusters: (i) medical expert-to-patient relationships, (ii) 
patient-to-patient relationships, and (iii) other stakeholder-to-patient relationships. 
Secondly, health 2.0 can be classified along the degree of community interaction. 
On the one hand, there are online sites which do not, or at least not to a recognizable 
extent, have a dedicated interaction focus. These are mostly sites characterized by 
unilateral information dissemination, e.g., NetDoktor. On the other hand, online 
platforms with well-developed communities, such as Imedo, GemeinsamSelten and 
PatientsLikeMe, certainly have a higher degree of interaction. Different measures 
could be applied here: number of discussion posts, posts per community member, 
share of active members, etc. Hence, we propose a second dimension to classify 
health 2.0 platforms: it is about the degree of interaction along a simple scale of 
low-medium-high.
Another important discussion point is about risks in health 2.0. Of course, a fateful 
illness will not be cured by surfing on the web. The personal relationship between a 
patient and his doctor remains paramount. But patient-driven healthcare is a trend that 
takes up and people are going online to get more knowledgeable about their illness. It 
is a question if users who publish personal health information online fully understand 
the risks of harm and misuse and if platform operators are successful in enforcing 
privacy – on the one hand to create trust towards users, on the other hand to comply 
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with local law. Confidentiality needs to be closely monitored if patient data, even in 
anonymized and aggregated form, is sold to companies. Furthermore, user-generated 
data is still poorly controlled and factors such as over-reporting of symptoms, data 
quality, and selection bias might influence results.
5 Conclusion
Patient communities in the context of health 2.0 are still a developing topic. In a first 
step, we portrayed four examples in this field. Specifically we looked at the different 
implementation levels of virtual patient communities. With this at hand, we discussed 
two major dimensions that can help to classify health 2.0 platforms. One is about 
user’s interactions with other user groups like medical experts, other patients, and 
industry or nonprofit partner. Another is about the degree of interaction triggered by 
the user community, which runs from low degree of interaction with predominant 
focus on information only to high degree of interaction between community members.
Results of this study have to be seen in the light of its limitations which also opens a 
number of research questions.
Firstly, the classification approach is conceptual only at this point in time. On the 
one hand, we only discussed two dimensions while other relevant scales, e.g., user 
segmentation or innovation focus, fall off. On the other hand, it lacks empirical 
foundation which is needed to substantiate it over time.
Secondly, it is easy to start a debate over blurring lines between clusters of a 
dimension. For example, the ‘degree of interaction’ is based on an ordinal scale only 
and yet remains open to be measured on a metric scale. Nevertheless, we believe the 
two dimensions serve a functional purpose: they assist in quickly differentiating the 
wealth of health-related sites from a community-research perspective. 
For future research, findings from studies on interaction in online and offline 
communities need to be connected to the context of patients and other stakeholders 
involved in health 2.0. Beyond that, a thorough understanding of interaction and 
collaboration between all involved parties is required in order to study the emergence 
of innovation on health 2.0 platforms.
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